Bank of America
AVEO

Bank of America’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Bank of America’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-50
Closed -$1K – 8263
2013
Q3 		$1K Sell
50
-10
-17% -$229 ﹤0.01% 7776
2013
Q2 		$2K Buy
+60
New +$2.56K ﹤0.01% 7536

Bank of America's AVEO Position: Q1 2023 in Review

Bank of America sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 21,854 shares — an estimated $327K sold.

Bank of America first reported a position in AVEO in Q2 2013 and held it in 36 quarters. The position peaked at $573K in Q3 2021. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

  • Bank of America reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Bank of America sold 21,854 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $327K.
  • Bank of America first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 36 quarters.
  • Bank of America's AVEO Pharmaceuticals, Inc. position peaked at $573K in Q3 2021.
  • 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Bank of America's 13F filing for Q1 2023, filed 12 May 2023.